Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Breast Cancer News ••• Topics • Countries • U.S. States

Metastatic Breast Cancer News Monitoring

Get by Email • RSS

Published on 02:06 GMT

Avutometinib/Abemaciclib/Fulvestrant Combo Is Active, Safe in CDK4/6 Inhibitor–Resistant HR+/HER2– Metastatic Breast ...

The combination of avutometinib (VS-6766), abemaciclib (Verzenio), and fulvestrant (Faslodex) demonstrated a manageable safety profile and preliminary efficacy in patients with hormone receptor (HR)–positive, HER2-negative metastatic breast cancer (HR+…

Source: OncLive - Pending
Published on Apr 28, 2025

Bria-IMT Plus Checkpoint Inhibition Is Safe and Yields Clinical Benefit in Pretreated Metastatic Breast Cancer

Treatment with the off-the-shelf, targeted, cell-based immunotherapy Bria-IMT (SV-BR-1-GM) in combination with an immune checkpoint inhibitor demonstrated favorable safety, tolerability, and evidence of clinical benefit in heavily pretreated patients with …

Source: OncLive - Pending
Published on Apr 26, 2025

84 EQUALS: Vaginal/Sexual Health in Patients With Estrogen Receptor–Positive/HER2- Metastatic Breast Cancer

Background/Significance Vagina/sexual health issues are common but under-recognized and understudied in women with breast cancer being treated with endocrine therapy. The EQUALS (ELAINE ESR1 QUAlity of Life Survey) explored quality of life and …

Source: Cancer Network - New Jersey - Pending
Published on 12:27 GMT

Novartis AG (NYSE:NVS) Q1 2025 Earnings Call Transcript

Novartis AG (NYSE:NVS) Q1 2025 Earnings Call Transcript April 29, 2025 Novartis AG beats earnings expectations. Reported EPS is $2.28, expectations were $2.12. Operator: Good morning and good afternoon, and welcome to the Novartis Q1 2025 Results Release …

Source: Insider Monkey - Neutral
Published on 12:45 GMT

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations ...

SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent …

Distribution channels: Law ...
Published on 11:30 GMT

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response ...

Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 study Biomarkers could be utilized to predict and provide better patient outcomes, including response rates and survival benefits Positive …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on 07:48 GMT

AstraZeneca discontinues Phase 3 trial of Truqap in metastatic castration-resistant prostate cancer

AstraZeneca has announced the discontinuation of the CAPItello-280 Phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) compared to docetaxel and ADT with placebo …

Source: Medical Dialogues - Indeterminate
Published on 10:00 GMT

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for ...

ATHENS, Greece and LOS ANGELES, April 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in the EMEA region, today announced that it has signed an agreement with Puma …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on 06:49 GMT

AstraZeneca to discontinue CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer

AstraZeneca is discontinuing the CAPItello-280 phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) compared to docetaxel and ADT with placebo in patients with …

Source: Pharmabiz.com - Neutral
Published on Apr 26, 2025

86 Elacestrant Combinations in Patients With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic ...

Background After first-line endocrine therapy (ET) plus CDK4/6 inhibitor (CDK4/6i) in estrogen receptor–positive/HER2-negative (ER+/HER2–) metastatic breast cancer, tumors eventually develop resistance. In the phase 3 EMERALD trial ( …

Source: Cancer Network - New Jersey - Pending
Published on Apr 26, 2025

Dr Desai on the Role of Palbociclib in HR+, HER2+ Metastatic Breast Cancer

“The data are compelling—I certainly would consider adding palbociclib in the maintenance phase for patients who [have] both hormone receptor–positive and HER2-positive metastatic disease.” Neelam Desai, MD, a breast medical oncologist and hematologist at …

Source: OncLive - Pending
Published on 00:17 GMT

From Prevention for Daiichi-Sankyo | AstraZeneca

Sitting on the stoop of her Pittsburgh home, Lauren assembles seasonal wreaths as she reflects on how far she has come since being diagnosed with stage IV metastatic breast cancer, or mBC. “Today, I’m in the best place I’ve ever been mentally. I’m looking …

Source: Prevention - Pending
Published on 00:17 GMT

TROP2 as Alternative Target for Metastatic Prostate Cancer Imaging and Therapy "Presentation" - Tanya Stoyanova

Read the Full Video Transcript Tanya Stoyanova: So first of all, I would like to thank the organizers for having me here today with you, and giving me the opportunity to share some of our work, and the work of others, on other targets-- other attractive …

Source: UroToday - Neutral
Published on Apr 25, 2025

87 Elacestrant Plus Abemaciclib Combination in Patients With Estrogen Receptor-positive, HER2-Negative Advanced or ...

Background After first-line endocrine therapy (ET) plus CDK4/6 inhibitor (CDK4.6i) in estrogen receptor–positive/HER2-negative (ER+/HER2–) metastatic breast cancer, tumors develop resistance to intrinsic alterations in the cell cycle or PI3K…

Source: Cancer Network - New Jersey - Pending
Published on Apr 29, 2025

Marjan Thérèse Ovinge Wikkerink

August 22, 1968 - April 16, 2025 In loving memory ~ Marjan Thérèse Ovinge Wikkerink went to be with her Lord and Saviour Jesus Christ on April 16, 2025. Marjan was born on August 22, 1968 in Assen, The Netherlands to Jan and Johanna Ovinge. She is survived …

Source: Cowichan Valley Citizen - Pending
Published on Apr 29, 2025

Meta Launches AI App To Compete With ChatGPT, Gemini, Grok

Novartis AG NVS reported first-quarter 2025 adjusted earnings per share of $2.28, beating the street view of $2.10. Quarterly sales of $13.23 billion marginally outpaced the analyst consensus estimate of $13.12 billion. Quarterly net sales grew 12% (+15% …

Source: Benzinga - Neutral
Published on Apr 29, 2025

Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk ...

SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a pioneering …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Apr 29, 2025

Immutep Quarterly Activities Report Q3 FY25

Media Release First patient safely dosed in TACTI-004 Phase III lung cancer trial, marking a significant milestone Pivotal TACTI-004 trial design presented at the European Lung Cancer Congress (ELCC) 2025 Patient enrolment completed for the EFTISARC-NEO …

Distribution channels: Technology ...
Published on Apr 28, 2025

Proactive ctDNA Monitoring May Guide Earlier Intervention in Endocrine-Resistant HR+/HER2– Breast Cancer

A growing body of evidence suggests that serial monitoring via circulating tumor DNA (ctDNA) could enable early detection of resistance mutations, including ESR1, prior to radiographic progression, which may allow for earlier intervention to help improve …

Source: OncLive - Pending

05 days 14:50:50

Featured Releases

Got News to Share? · Submit · See All

Published on April 30, 2025 - 10:00 GMT

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for ...

ATHENS, Greece and LOS ANGELES, April 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in the EMEA region, today announced that it has signed an agreement with Puma …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on April 29, 2025 - 17:23 GMT

Employers Face Rising Breast Cancer Costs – There’s Now An App (Benefit) For That

Last week, Know Your Lemons app beat out Apple’s premiere fitness app by being named the Top Health, Wellness, and Fitness app in the world by the Webby Awards. SALT LAKE CITY, UT, UNITED STATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- This week a unique …

Distribution channels: Business & Economy, Companies ...

Published on April 29, 2025 - 12:45 GMT

Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk ...

SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a pioneering …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 29, 2025 - 12:30 GMT

CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany

Dr. Jacob Lalezari, CEO, and Dr. Richard Pestell, Lead Consultant in Preclinical and Clinical Oncology, to lead CytoDyn group in attendance VANCOUVER, Washington, April 29, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on April 30, 2025 - 12:45 GMT

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations ...

SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent …

Distribution channels: Law ...
Published on April 30, 2025 - 11:30 GMT

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response ...

Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 study Biomarkers could be utilized to predict and provide better patient outcomes, including response rates and survival benefits Positive …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 12:00 GMT

2025 NAUMD Awards Celebrate Excellence in Uniforms That Work Hard and Wear Well

NAUMD honors 2025’s top uniform programs, celebrating innovation, identity, safety, and sustainability across industries worldwide. SAUGERTIES, NY, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- The Network Association of Uniform Manufacturers and …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...
Published on April 28, 2025 - 11:00 GMT

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 ...

CDK2 molecular glue degrader (MGD) in combination with CDK4/6 inhibition and anti-estrogen therapy achieved superior tumor regression in vivo compared to standard of care CDK4/6 inhibition and anti-estrogen therapy CDK2 MGD delayed resistance to …

Distribution channels: Technology ...

Got news to share? Submit it now.

Load more breast cancer news or search news using your own keywords. There are 808,102,329 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Breast Cancer News by Country

Breast Cancer News by U.S. State

Breast Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on April 30, 2025 - 13:06 GMT

Enabled Therapeutics Announces Board Appointment of Jivan Achreja as It Introduces a New Era in Precision Neurology

Enabled Therapeutics strengthens leadership team as it redefines neurology with on-site drug synthesis and precision brain therapeutics. SAN FRANCISCO, CA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Enabled Therapeutics, a company …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 13:00 GMT

Congratulations to Martha Selmon of USC, the 2025 CAHME/Nancy Rosenthal Scholarship Recipient

SPRING HOUSE , PA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Martha Selmon, a Master of Healthcare Administration (MHA) Candidate at the University of South Carolina, has been named the 2025 recipient of the CAHME/Nancy Rosenthal Scholarship. …

Distribution channels: Companies, Education ...
Published on April 30, 2025 - 13:00 GMT

Congratulations to Merry Jiang of JHU, the 2025 CAHME/Olin Oedekoven Scholarship Recipient for Most Improved Student

SPRING HOUSE , PA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Merry Jiang, a Master of Healthcare Administration (MHA) Candidate at Johns Hopkins University, has been named the 2025 recipient of the CAHME/Olin Oedekoven Scholarship for Most …

Distribution channels: Companies, Education ...
Published on April 30, 2025 - 13:00 GMT

Two Chairs Launches Psychiatry Services, Expanding Access to Integrated Mental Health Care

New offering makes therapy and psychiatry services available in one place SAN FRANCISCO, CA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Two Chairs, a provider of comprehensive, high-quality mental health care, today announced the launch …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on April 30, 2025 - 12:58 GMT

Lumen Apposing Metal Stent Market anticipated to reach US$4.720 billion by 2030 at a CAGR of 5.12%

The lumen apposing metal stent market is anticipated to grow at a CAGR of 5.12% from US$3.678 billion in 2025 to US$4.720 billion by 2030. NEW YORK, NY, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- According to a new study published by …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 12:53 GMT

Cholangioscopy Market projected to achieve a CAGR of 7.19% to reach US$14.820 billion

The cholangioscopy market is anticipated to grow at a CAGR of 7.19% from US$10.476 billion in 2025 to US$14.820 billion by 2030. NEW YORK, NY, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- According to a new study published by Knowledge …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 12:48 GMT

Drug Eluting Stent Market anticipated to surpass US$17.049 billion by 2030 at a CAGR of 8.20%

The drug eluting stent market is anticipated to grow at a CAGR of 8.20% from US$11.499 billion in 2025 to US$17.049 billion by 2030. NEW YORK, NY, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- According to a new study published by …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 12:45 GMT

Florida Spine Associates Patients Reclaim Their Health and Confidence with Prescribe FIT

BOYNTON BEACH, FL, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Florida Spine Associates, known for their commitment to comprehensive, patient-centered spine care, is seeing extraordinary results thanks to their new Prescribe FIT virtual health …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 12:39 GMT

New Acquisitions Joins 20th Anniversary PanCAN PurpleStride to Honor Survivors & Support Fight Against Pancreatic Cancer

New Acquisitions joined PanCAN’s 20th PurpleStride 5K in Atlanta, walking for awareness and in support of our HR Manager’s mom, a proud cancer survivor. ATLANTA, GA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- New Acquisitions was proud …

Distribution channels: Business & Economy, Companies ...
Published on April 30, 2025 - 12:00 GMT

Beckfield College Nursing Programs Achieve Outstanding NCLEX Pass Rates in 2024

Highlighting student success and major gains across all nursing programs. FLORENCE, KY, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Beckfield College is proud to announce its 2024 NCLEX pass rates, highlighting the exceptional quality and …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on April 30, 2025 - 12:00 GMT

SCAN Health Plan Opens First-Ever Storefront in Henderson, Nevada

Invite-Only Grand Opening Celebration and Ribbon Cutting Ceremony Scheduled for May 6 LONG BEACH, CA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- SCAN Health Plan, one of the nation’s largest not-for-profit Medicare Advantage health plans, is …

Distribution channels: Business & Economy, Companies ...
Published on April 30, 2025 - 12:00 GMT

CD Bioglyco Unveils Comprehensive Hot Glycans Catalog to Support Global Glycobiology Advancements

CD Bioglyco's Hot Glycans offers key glycan structures & custom services for disease research, featuring N-/O-glycans, with QC validation. NEW YORK, NY, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- CD Bioglyco, the leading platform for …

Distribution channels: Chemical Industry, Companies ...
Published on April 30, 2025 - 12:00 GMT

Eleven Barton Gilman Attorneys Named to 2025 Rhode Island Super Lawyers and Rising Stars Lists

PROVIDENCE, RI, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Eleven Barton Gilman attorneys have been named to the 2025 Rhode Island Super Lawyers and Rising Stars lists, a directory of leading attorneys who are evaluated on various measures of …

Distribution channels: Business & Economy, Education ...
Published on April 30, 2025 - 12:00 GMT

Small Biopsies, Big Insights: How Tiny Tissue Samples Could Transform Glioblastoma Research

New study from Break Through Cancer TeamLab unveils the power of investigational biopsies, unlocking a promising tool for real-time monitoring of glioblastoma CAMBRIDGE, MA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Glioblastoma (GBM) is a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on April 30, 2025 - 11:59 GMT

New Book by Sales Strategist Tom Jackobs Offers Step-by-Step Framework for Heart-Centered Selling

Tom Jackobs helps mission-driven professionals boost sales without sleaze in his new book, Selling With H.E.A.R.T. LOS ANGELES, TX, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- In a refreshing take on ethical sales, international speaker …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on April 30, 2025 - 11:54 GMT

Findability Sciences Deepens Global AI Footprint with Strategic Multi-Million Dollar Expansion in Mumbai, India

New Mumbai Hub and Innovation & Delivery Centre Poised to Boost Innovation, Enhance Global Client Delivery, and Accelerate AI-driven Growth BOSTON, MA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Findability Sciences, a leading …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 11:53 GMT

Revival Research Institute Aligns Strategy and Support at Upcoming All-Hands Meeting, May 2025

SOUTHFIELD, MI, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Revival Research Institute is proud to announce its upcoming 𝐀𝐥𝐥-𝐇𝐚𝐧𝐝𝐬 𝐌𝐞𝐞𝐭𝐢𝐧𝐠, set to take place on 𝐌𝐚𝐲 𝟐, 𝟐𝟎𝟐𝟓 Themed “Digitally Driven, Process Powered: The Future of Clinical …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 11:45 GMT

Jane Partners with Whereby to Deliver Secure and Reliable Virtual Healthcare Appointments

Whereby, a leading video conferencing provider, is proud to announce its partnership with Jane.app VANCOUVER, CANADA, April 30, 2025 /⁨EINPresswire.com⁩/ -- Whereby, a leading video conferencing provider, is proud to announce its partnership with …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on April 30, 2025 - 11:30 GMT

Therasage Announces TheraVibe™: A New Advancement in Wearable Wellness Technology

herasage unveils TheraVibe™, a new line of wearable frequency-infused patches designed to support natural energy, recovery, and vitality. CALIFORNIA, CA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Therasage, a leading innovator in …

Distribution channels: Beauty & Hair Care, Consumer Goods ...
Published on April 30, 2025 - 11:00 GMT

Hidden Strength Releases New Survey on the State of Mental Health for Teenagers

LONDON, UNITED KINGDOM, April 30, 2025 /⁨EINPresswire.com⁩/ -- Hidden Strength, a digital platform and app designed to give free therapy and support the mental wellness of teenagers and young adults, announced the results of its comprehensive …

Distribution channels: Culture, Society & Lifestyle, Education ...